Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro

8 May 2015

Abstract excerpt

// Helen Künstlinger 1 , Jana Fassunke 1 , Hans-Ulrich Schildhaus 2 , Benedikt Brors 3 , Carina Heydt 1 , Michaela Angelika Ihle 1 , Gunhild Mechtersheimer 4 , Eva Wardelmann 5 , Reinhard Büttner 1 and Sabine Merkelbach-Bruse 1 1 Institute of Pathology, University Hospital Cologne, Cologne, Germany 2 Institute of Pathology, University Hospital Göttingen, Göttingen, Germany 3 Computational Oncology, German Cancer...

Topics

Join the communities discussing this publication.

Fibroblast Growth Factor Research
Proteoglycans and glycosaminoglycans research
Sarcoma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26036639
DOI: 10.18632/oncotarget.4046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitroPMID 26036639Read ↗

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual TargetingSemantic proximity Read ↗

Targeting liposarcoma: unveiling molecular pathways and therapeutic opportunitiesSemantic proximity Read ↗

Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicin.Semantic proximity Read ↗

Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy SelectionSemantic proximity Read ↗

Cytogenetics and Molecular Genetics of Myxoid Soft-Tissue SarcomasSemantic proximity Read ↗

Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical TreatmentSemantic proximity Read ↗

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma.Semantic proximity Read ↗

miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signalingSemantic proximity Read ↗

Clinical and Molecular Spectrum of LiposarcomaSemantic proximity Read ↗

Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma.Semantic proximity Read ↗

Liposarcoma: Molecular Genetics and TherapeuticsSemantic proximity Read ↗

Therapeutic opportunity of phosphodiesterase 3A modulators in myxoid liposarcomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.